ISCHEMIA TRIAL

Improving outcome in aneurysmal subarachnoid hemorrhage with nadroparin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23094

Enrollment

Registered

2017-10-08

Start date

2018-01-01

Completion date

Unknown

Last updated

2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aneurysmal subarachnoid hemorrhage

Interventions

High-dose nadroparin

Eligibility

Inclusion criteria

Inclusion criteria: Adult Occluded aneurysm

Exclusion criteria

Exclusion criteria: untreated aneurysm

Design outcomes

Primary

Measure	Time frame
in hospital mortality	—

Secondary

Measure	Time frame
Peri-procedural complications, hemorrhagic complications, outcome using modified Rankin Scale, health costs	—

Contacts

Public ContactD. Verbaan

AMC Meibergdreef 9

D.Verbaan@amc.uva.nl+31 (0)20 5666564

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)